913626-21-8

Basic information

• Product Name: 5-(4-bromo-phenyl)-5-(4-tert-butoxycarbonyl-3-oxo-butoxy)-3-oxo-pentanoic acid ethyl ester
• Synonyms: 5-(4-bromo-phenyl)-5-(4-tert-butoxycarbonyl-3-oxo-butoxy)-3-oxo-pentanoic acid ethyl ester
• CAS NO: 913626-21-8
• Molecular Weight: 485.372
• Mol File: 913626-21-8.mol

Chemical Properties

• CAS DataBase Reference: 5-(4-bromo-phenyl)-5-(4-tert-butoxycarbonyl-3-oxo-butoxy)-3-oxo-pentanoic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-bromo-phenyl)-5-(4-tert-butoxycarbonyl-3-oxo-butoxy)-3-oxo-pentanoic acid ethyl ester(913626-21-8)
• EPA Substance Registry System: 5-(4-bromo-phenyl)-5-(4-tert-butoxycarbonyl-3-oxo-butoxy)-3-oxo-pentanoic acid ethyl ester(913626-21-8)

Safety Data

• Hazardous Substances Data: 913626-21-8(Hazardous Substances Data)

Upstream product

• 221898-37-9 (S)-1-(4-bromophenyl)but-3-en-1-ol 
• 5292-43-3 bromoacetic acid tert-butyl ester 
• 913626-20-7 5-[1-(4-bromo-phenyl)-but-3-enyloxy]-3-oxo-pentanoic acid tert-butyl ester 
• 913626-19-4 3-[(1S)-1-(4-bromo-phenyl)-but-3-enyloxy]-propionitrile 
• 623-73-4 diazoacetic acid ethyl ester 

Downstream Products

• 913626-29-6 C₆₅H₁₁₇BrO₁₄Si₄ 
• 913626-18-3 Octanoic acid (E)-(1S,5S,9S,11S,15R,19R,21S,24S)-11-(4-bromo-phenyl)-1,15-dihydroxy-19-hydroxymethyl-23-[1-methoxycarbonyl-meth-(E)-ylidene]-2,2-dimethyl-17-oxo-6,12,18,25,26-pentaoxa-tricyclo[19.3.1.1^5,9]hexacos-3-en-24-yl ester 
• 1026938-43-1 5-[1-(4-bromo-phenyl)-3,5-bis-(tert-butyl-dimethyl-silanyloxy)-pentyloxy]-3-(tert-butyl-dimethyl-silanyloxy)-pentanoic acid 
• 913626-28-5 (R)-5-[(1S,3S)-1-(4-Bromo-phenyl)-3,5-dihydroxy-pentyloxy]-3-hydroxy-pentanoic acid tert-butyl ester 
• 913626-22-9 (3R,5S)-5-(4-Bromo-phenyl)-5-((R)-4-tert-butoxycarbonyl-3-hydroxy-butoxy)-3-hydroxy-pentanoic acid ethyl ester 

Relevant articles and documents

Synthesis and PKC binding of a new class of A-ring diversifiable bryostatin analogues utilizing a double asymmetric hydrogenation and cross-coupling strategy

The design, asymmetric synthesis, and biological evaluation of a new class of bryostatin analogues based on a pseudosymmetric spacer domain are described. An aryl bromide diversification site is incorporated allowing access to systematically varied analog